Marshall Wace’s Organogenesis Holdings ORGO Stock Holding History

Marshall Wace’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,114	Closed	-$42.9K	–	2845
2024 Q1	$42.9K	Sell	15,114 -807,040	-98%	-$2.74M	﹤0.01%	2353
2023 Q4	$3.36M	Buy	822,154 +362,115	+79%	+$1.01M	0.01%	1047
2023 Q3	$1.46M	Sell	460,039 -473,482	-51%	-$1.5M	﹤0.01%	1365
2023 Q2	$3.1M	Buy	933,521 +222,692	+31%	+$658K	0.01%	1210
2023 Q1	$1.51M	Buy	+710,829	New	+$1.76M	﹤0.01%	1612
2022 Q4	–	Sell	-29,233	Closed	-$95K	–	3292
2022 Q3	$95K	Buy	+29,233	New	+$132K	﹤0.01%	3193
2022 Q2	–	Sell	-443,778	Closed	-$3.38M	–	3727
2022 Q1	$3.38M	Buy	+443,778	New	+$3.43M	0.01%	1702
2021 Q4	–	Sell	-52,119	Closed	-$742K	–	4183
2021 Q3	$742K	Buy	+52,119	New	+$809K	﹤0.01%	2188
2021 Q2	–	Sell	-157,794	Closed	-$2.88M	–	2961
2021 Q1	$2.88M	Sell	157,794 -70,231	-31%	-$952K	0.01%	1142
2020 Q4	$1.72M	Buy	+228,025	New	+$1.08M	0.01%	1010
2020 Q1	–	Sell	-37,418	Closed	-$180K	–	1947
2019 Q4	$180K	Buy	+37,418	New	+$237K	﹤0.01%	1363

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's ORGO Position: Q2 2024 in Review

Marshall Wace sold out of Organogenesis Holdings (ORGO) in Q2 2024, closing a stake of 15,114 shares — an estimated $42.9K sold.

Marshall Wace first reported a position in ORGO in Q4 2019 and held it in 11 quarters. The position peaked at $3.38M in Q1 2022. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2024.

Marshall Wace reported no remaining Organogenesis Holdings position as of Q2 2024 after selling out during the quarter.
Marshall Wace sold 15,114 Organogenesis Holdings shares in Q2 2024, an estimated $42.9K.
Marshall Wace first reported a position in Organogenesis Holdings in Q4 2019 and held it in 11 quarters.
Marshall Wace's Organogenesis Holdings position peaked at $3.38M in Q1 2022.
115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2024.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.